(Q37598728)

21 August 2017

title

The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx (English)

1 reference

21 August 2017

0 references

squamous cell carcinoma

1 reference

7

Randal S Weber

1 reference

21 August 2017

Mark E Zafereo

1

1 reference

21 August 2017

Matthew M Hanasono

2

1 reference

21 August 2017

David I Rosenthal

3

1 reference

21 August 2017

Erich M Sturgis

4

1 reference

21 August 2017

Jan S Lewin

5

1 reference

21 August 2017

Diana B Roberts

6

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

21 August 2017

number of pages

11

1 reference

inferred from page(s)

published in

Cancer

1 reference

21 August 2017

volume

115

1 reference

21 August 2017

issue

24

1 reference

21 August 2017

page(s)

5723-5733

1 reference

RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

Oromandibular reconstruction using microvascular composite flaps: report of 210 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Squamous cell carcinoma of the oropharynx: why we fail

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Changes in treatment of advanced oropharyngeal cancer, 1985-2001

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Recurrence patterns in squamous cell carcinoma of the oral cavity, pharynx, and larynx

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Surgical management of postradiation residual/recurrent cancer of the base of the tongue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Primary and salvage surgery for cancer of the tonsillar region: a retrospective study of 120 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Salvage surgery with free flap reconstruction: factors affecting outcome after treatment of recurrent head and neck squamous carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Platinum-based chemotherapy plus cetuximab in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Natural history of untreated head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Time to recurrence of squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Survival of patients who needed salvage surgery for recurrence after radiotherapy for oral carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Biological markers and prognosis in recurrent oral cancer after salvage surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Postoperative complications after en bloc salvage surgery for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Histologic characteristics and tumor spread of recurrent glottic carcinoma: analysis on whole-organ sections and comparison with tumor spread of primary glottic carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Treatment of recurrent and advanced stage squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Quality of life and disease-specific functional status following microvascular reconstruction for advanced (T3 and T4) oropharyngeal cancers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Cost effectiveness in context

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Measuring economic outcomes of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24595

7 January 2021

Identifiers

DOI

10.1002/CNCR.24595

1 reference

21 August 2017

1 reference